prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, RUN DATE : RUN TIME: RUN USER. Lab Database : LOC: U # : AGE/SX: ROOM. REG DR: BED: DIS : TLOC: SPEC #:1. RECD: COLL. TIME IN FORMALIN: 7:21. hrs. CLINICAL INFORMATION: Pre-Op Diagnosis: Left breast cancer. Remarks: Specimen (s) : A. Left breast lumpectomy. B. Left breast new lateral margin. C. Left axillary sentinel node. MICROSCOPIC DIAGNOSIS. A. LEFT BREAST TISSUE. LUMPECTOMY: INFILTRATING DUCTAL CARCINOMA. MODIFIED NOTTINGHAM HISTOLOGIC GRADE 3 OF 3: NUCLEAR SCORE 3 OF 3, TUBULE. FORMATION SCORE 3 OF 3. MITOTIC SCORE 3 OF 3 (11 MITOTIC FIGURES PER SQUARE. MILLIMETER). NO DUCTAL CARCINOMA IN SITU IDENTIFIED. INVASIVE TUMOR MEASURES 13 MM. LATERAL SURGICAL MARGIN OF THIS SPECIMEN FOCALLY INVOLVED (RE-EXCISED BELOW) ,. TUMOR PRESENT 2 MM FROM MEDIAL MARGIN. SEE COMMENT FOR SYNOPTIC REPORT. B. EXCISION LESION BREAST TISSUE, NEW LATERAL MARGIN: NO TUMOR SEEN. FIBROCYSTIC CHANGES. C. ONE LYMPH NODE. LEFT AXILLARY SENTINEL, LYMPHADENECTOMY: NO TUMOR SEEN IN MULTIPLE STEP SECTIONS STAINED WITH ROUTINE AND PANKERATIN. IMMUNOCHEMICAL STAINS. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - CAP APPROVED: Procedure: Excision without wire-guided localization. Lymph Node Sampling. Sentinel lymph node (s). Specimen Laterality: Left. Histologic Type of Invasive Carcinoma : Invasive ductal carcinoma. Tumor Size: Greatest dimension of largest focus of invasion >1. mm: 13 mm. Histologic Grade Nottingham) : Glandular/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 3. RUN DATE. RUN TIME : Specimen Inquiry. RUN USER. SPEC #: COMMENT (s). Mitotic Rate: Score 3. Overall Grade: Grade 3. Tumor Focality: Single focus of invasive carcinoma. Ductal Carcinoma In Situ: No DCIS is present. Margins: Invasive Carcinoma: Margins uninvolved by invasive. carcinoma. Distance from closest margin: 2 mm: medial. Lymph Nodes: Number of sentinel lymph nodes examined : 1. Total number of lymph nodes examined (sentinel and. nonsentinel) : 1. Number of lymph nodes with macrometastases (>2 mm). 0. Number of lymph nodes with micrometastases (>0.2 mm. to 2 mm and/or >200 cells) 0. Number of lymph nodes with isolated tumor cells. (<0.: 2 mm and <200 cells): 0. Number of lymph nodes without tumor cells. identified: 1. Pathologic Staging: Primary Tumor pT1b. Regional Lymph Nodes: Modifier: (sn). Category: pNO (i-). Distant Metastasis: Not applicable. Ancillary Studies: ER: Negative (<1% of tumor cells with nuclear. positivity). PR: Negative ( <1% of tumor cells with nuclear. positivity). HER2 Immunoperoxidase Studies: Negative (Score 1+). GROSS DESCRIPTION: The specimen is received in the fresh state in three parts for immediate gross evaluation. A. This specimen is received for tumor banking and evaluation of the surgical margins. and. consist of an excision of breast tissue which measures 4 x 4 x 2.5 cm. Present on the. surface is an ellipse of light brown skin measuring 3 x 0.7 cm. The surgeon has tagged the. surgical margins with this as reference, I have inked the margins as follows: Blue is lateral. Yellow is inferior. Black is medial. Red is superior. Orange is deep. Sectioning reveals a firm, stellate, tan tumor which measures 13 mm in greatest dimension. The tumor focally touches the lateral margin. The next nearest margin is medial at 2 mm. The remaining margins are greater than 1 cm from tumor. À representative section of the. tumor is submitted for tumor banking. À recent biopsy site is present in the tumor. CONTINUED CN NEXT PAGE. RUN DATE. RUN TIME. Specimen Inquiry. RUN USEE. SPEC #: GROSS DESCRIPTION (Continued). Representative sections are submitted as blocks A1 through A5. B. This is an excision of breast tissue which measures 2 x 2 x 1 cm. The surgeon has. tagged the new lateral margin. I have applied blue ink to this margin No gross evidence. of residual tumor is present in this specimen. Representative sections are submitted as. blocks B1 and B2. C. This is a soft. tan lymph node which measures 15 x 10 x 5 mm, sectioned and totally. submitted as block C1 for sentinel node protocol. There is no gross evidence of metastatic. tumor. INTRAOPERATIVE CONSULTATION: IMMEDIATE GROSS EVALUATION A (BREAST EXCISION) : FOCAL TUMOR PRESENT AT LATERAL MARGINS WITH REMAINING MARGINS FREE OF TUMOR. IMMEDIATE GROSS EVALUATION B (RE-EXCISION LATERAL MARGIN) : NO GROSS EVIDENCE OF TUMOR. IMMEDIATE GROSS EVALUATION C (SENTINEL NODE) : NO GROSS EVIDENCE OF TUMOR. PHOTO DOCUMENTATION. Image. (signature on file).

expanded version (tokens=1541) : 
 Histological classification: Infiltrating ductal carcinoma
Subtype: HER2
Necrosis: None mentioned
Tumor infiltrating lymphocytes: None mentioned
Histological grade: Modified Nottingham histologic grade 3 of 3, nuclear score 3 of 3, tubule formation score 3 of 3, mitotic score 3 of 3
Nuclear grade: Score 3 of 3
Lymphovascular invasion: None mentioned
Calcification: None mentioned
Receptor status: 
- ER: Negative (<1% of tumor cells with nuclear positivity)
- PR: Negative (<1% of tumor cells with nuclear positivity)
- HER2 Immunoperoxidase Studies: Negative (Score 1+)
IHC and ancillary testing: None mentioned except HER2 Immunoperoxidase Studies.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1676) : 
 The breast pathology report shows a subtype of HER2 infiltrating ductal carcinoma, with a modified Nottingham histologic grade of 3 out of 3, and tumor size of 13mm. There is no evidence of necrosis or lymphovascular invasion. Hormone receptor status is negative for ER and PR, HER2 Immunoperoxidase Studies are negative (Score 1+). No other ancillary testing was mentioned.

